A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat.
Thermogenic brown and beige adipose tissues dissipate chemical energy as heat, and their thermogenic activities can combat obesity and diabetes. Herein the functional adaptations to cold of brown and beige adipose depots are examined using quantitative mitochondrial proteomics. We identify arginine/creatine metabolism as a beige adipose signature and demonstrate that creatine enhances respiration in beige-fat mitochondria when ADP is limiting. In murine beige fat, cold exposure stimulates mitochondrial creatine kinase activity and induces coordinated expression of genes associated with creatine metabolism. Pharmacological reduction of creatine levels decreases whole-body energy expenditure after administration of a β3-agonist and reduces beige and brown adipose metabolic rate. Genes of creatine metabolism are compensatorily induced when UCP1-dependent thermogenesis is ablated, and creatine reduction in Ucp1-deficient mice reduces core body temperature. These findings link a futile cycle of creatine metabolism to adipose tissue energy expenditure and thermal homeostasis. PAPERCLIP.
Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA.
Lawrence
L
Kazak
Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA.
Edward T
ET
Chouchani
Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA.
Mark P
MP
Jedrychowski
Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA.
Brian K
BK
Erickson
Diabetes Center, University of California, San Francisco (UCSF), San Francisco, CA 94143, USA.
Kosaku
K
Shinoda
Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA.
Paul
P
Cohen
Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Ramalingam
R
Vetrivelan
Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Gina Z
GZ
Lu
Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Dina
D
Laznik-Bogoslavski
Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA.
Sebastian C
SC
Hasenfuss
Diabetes Center, University of California, San Francisco (UCSF), San Francisco, CA 94143, USA.
Shingo
S
Kajimura
Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA.
Steve P
SP
Gygi
Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA. Electronic address: bruce_spiegelman@dfci.harvard.edu.
Bruce M
BM
Spiegelman
D000244:Adenosine Diphosphate / Q000378:metabolism; D000273:Adipose Tissue / Q000378:metabolism; D002001:Adipose Tissue, Brown / Q000378:metabolism*; D000818:Animals; D003401:Creatine / Q000378:metabolism*; D004734:Energy Metabolism; D006706:Homeostasis; D006801:Humans; D007473:Ion Channels / Q000378:metabolism; D051379:Mice; D008928:Mitochondria / Q000378:metabolism; D024101:Mitochondrial Proteins / Q000378:metabolism; D009765:Obesity / Q000378:metabolism; D022722:Thermogenesis; D000071256:Uncoupling Protein 1
D007473:Ion Channels; D024101:Mitochondrial Proteins; C000604371:UCP1 protein, human; C000604372:Ucp1 protein, mouse; D000071256:Uncoupling Protein 1; D000244:Adenosine Diphosphate; D003401:Creatine